CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 143 enrolled
Drug / intervention
etafilcon A with ketotifen +1 morecombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03388138
NCT03388138Phase 2Completed
CompareCT.gov

Clinical Evaluation of Etafilcon A With Ketotifen

Johnson & Johnson Vision Care, Inc.·interventional·Posted Jan 2, 2018·Updated Mar 17, 2022

In Brief

A Phase 2 clinical trial evaluating etafilcon A with ketotifen and 1-Day ACUVUE for Visual Acuity. Completed, enrolled 143 participants across 6 sites.

Detailed Summary

This clinical study is a randomized, double-masked, bilateral, controlled, two-arm parallel group, multi-site, 1-Week, 2-visit dispensing study. Subjects between the ages of 18-40 will be randomized into a placebo arm or an investigational K-Lens arm.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedJan 2, 2018
Enrollment StartDec 6, 2017
Primary CompletionFeb 9, 2018
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 8.5 years ago

Interventions

etafilcon A with ketotifencombination

Etafilcon A with ketotifen

1-Day ACUVUEdevice

1-Day ACUVUE